Mastodon

CardioM Potassium Magnesium (Tablets) Instructions for Use

Marketing Authorization Holder

Nizhpharm JSC (Russia)

Manufactured By

Walmark, a.s. (Czech Republic)

Contact Information

NIZHPHARM group of companies (Russia)

Dosage Form

Bottle OTC Icon CardioM Potassium Magnesium Coated tablets: 50 pcs.

Dosage Form, Packaging, and Product Composition

Coated tablets, weighing 1200 mg.

Composition anti-caking agent cellulose, potassium (Potassium citrate monohydrate), anti-caking agent calcium carbonate, magnesium (Magnesium citrate), tablet coating (stabilizer hypromellose, anti-caking agent magnesium hydrocarbonate, stabilizer hydroxypropylcellulose, anti-caking agent calcium phosphate dibasic, anti-caking agent microcrystalline cellulose), stabilizer crosslinked sodium carboxymethylcellulose, anti-caking agent magnesium stearate, vitamin B6 (pyridoxine hydrochloride), vitamin B12 (cyanocobalamin), folic acid.

50 pcs. – plastic jars.

Therapeutic Category

Dietary supplement for improving the functional state of the cardiovascular system

Properties

CardioM Potassium Magnesium is a dietary supplement for maintaining cardiovascular health with minerals that significantly reduce the risk of heart attack and stroke.

Potassium and magnesium nourish the heart and blood vessels, supporting the normal contraction of the heart muscle.

The product is fortified with B vitamins, which affect homocysteine – an amino acid associated with the risk of developing cardiovascular diseases.

The citrate form for improved absorption provides the highest solubility for better mineral absorption.

Scope of Application

Of the CardioM Potassium Magnesium product

  • As a dietary supplement – an additional source of magnesium, vitamins B6, B12, folic acid, containing potassium.

Indications

  • Use as a dietary supplement to serve as an additional source of magnesium, potassium, vitamin B6, vitamin B12, and folic acid.
  • Intended to support the functional state of the cardiovascular system.
  • Suitable for addressing other nutritional deficiencies as classified under ICD-10 code E63.

ICD codes

ICD-10 code Indication
E63 Other nutritional deficiencies

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally. For adults, the recommended dosage is two tablets taken twice daily.

The standard duration of administration is one month. This course may be repeated if deemed necessary by a healthcare provider.

Adhere strictly to the recommended dosage; do not exceed it.

Adverse Reactions

Adverse reactions are not commonly expected with this dietary supplement.

In cases of individual hypersensitivity to any component, allergic reactions such as skin rash, itching, or urticaria may occur.

Discontinue use immediately and consult a physician if any adverse effects are suspected or experienced.

Drug Interactions

No specific drug interaction studies have been conducted for this dietary supplement.

Exercise caution when taking concurrently with potassium-sparing diuretics or other mineral supplements, as this may lead to elevated mineral levels.

Inform your physician about all medications and supplements you are taking prior to use to assess potential interactions.

Contraindications

  • Hypersensitivity to any of the product’s components, including excipients.
  • Pregnancy due to the lack of sufficient safety data for use during this period.
  • Breastfeeding due to the unknown excretion of components into human milk and potential risk to the infant.

Overdose

Symptoms of overdose may include manifestations of hyperkalemia (e.g., muscle weakness, paresthesia, cardiac arrhythmias) or hypermagnesemia (e.g., nausea, vomiting, flushing, bradycardia).

In case of suspected overdose, discontinue use immediately and seek prompt medical attention.

Treatment is symptomatic and supportive; specific measures may include monitoring electrolyte levels and cardiac function.

Dispensing Status

Places of sale are determined by the national legislation of the member states of the Eurasian Economic Union.

Storage Conditions

The product should be stored in a dry place, protected from direct sunlight, out of reach of children, at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 2 years.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS